Skip to content

Telesair

Portable high-flow oxygen therapy device

Raised to date

$3M

of $6M offered across 1 Form D filing

Still open
$3M
Investors
12
Last filed
Mar 18, 2026

About

Telesair is a medical technology startup founded in 2020 that develops compact and mobile respiratory care solutions. The company's primary focus is on enabling earlier patient discharge from hospitals to home settings, aiming to improve outcomes for individuals with respiratory insufficiency.

The company stands out by designing and manufacturing its cost-effective and user-friendly High Flow Oxygen Therapy (HFOT) system in the United States, led by veterans from the respiratory industry. Telesair achieved rapid regulatory success, obtaining both an MDR CE Mark and FDA clearance for its primary product in less than one year.

Funding

  • EquityFiled Mar 18, 2026Form D
    $3M/ $6M

Product

Bonhawa High Flow Oxygen Therapy (HFOT) system

Oxygen Therapy System

The Bonhawa is a standalone, lightweight, and mobile device designed to treat respiratory insufficiency. It delivers high flows of oxygen up to 80 L/min and is designed to support patient mobility and smooth a patient's transition from the hospital to a homecare setting.

  • Compact and mobile design for increased patient mobility
  • Instantly ready for use upon power-up
  • Touch screen that is visible from a hallway

Built for

Telesair targets a range of healthcare providers, including hospitals, long-term care facilities, skilled nursing facilities, rural health providers, and homecare settings.

People on file